Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR-mutated NSCLC treated with afatinib.

Thoracic cancer - 1 Sept 2023

Wu Chen-Te, Hsu Ping-Chih, Chang John Wen-Cheng, Chang Ching-Fu, Huang Chen-Yang, Yang Cheng-Ta, Kuo Chih-Hsi Scott, Fang Yueh-Fu, Wu Chiao-En

Abstract excerpt

BACKGROUND: This study aimed to comprehensively evaluate the efficacy and toxicity of afatinib in patients with sarcopenia, an important prognostic factor for treatment efficacy and toxicity in patients with cancer. METHODS: The clinical features of patients with advanced NSCLC treated with frontline afatinib between 2014 and 2018 at a medical center in Taiwan were retrospectively reviewed. Sarcopenia was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Afatinib
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Mutation

Share to Protein Kinase Inhibitors

Share to Sarcopenia

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 37525557
DOI: 10.1111/1759-7714.15017
PMCID: PMC10481145

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR-mutated NSCLC treated with afatinib.PMID 37525557Read ↗

The effect of sarcopenia on erlotinib therapy in patients with metastatic lung adenocarcinoma.Semantic proximity Read ↗

Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations?Semantic proximity Read ↗

Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase InhibitorsSemantic proximity Read ↗

Development and Validation of a Clinically Useful Nomogram for Predicting Sarcopenia in Bone Tumor PatientsSemantic proximity Read ↗

The Impact of Sarcopenia on Overall Survival in Patients with Pan-RAS Wild-type Colorectal Liver Metastasis Receiving HepatectomySemantic proximity Read ↗

Independent and joint association of sarcopenia and frailty with mortality in older patients with gastrointestinal cancer: A cohort study with prospective data collectionSemantic proximity Read ↗

Could Sarcopenia be Related to Chemotherapy in Gastrointestinal Cancer? A Cross-Sectional Study Including Comprehensive Geriatric AssessmentSemantic proximity Read ↗

Prevalence and associated factors of sarcopenia in cervical cancer patients undergoing chemotherapySemantic proximity Read ↗

Risk factors of sarcopenia in patients with esophageal squamous cell carcinomaSemantic proximity Read ↗

Nutritional status and drug resistance in EGFR-mutant NSCLC: a retrospective cohort study on almonertinib efficacy.Semantic proximity Read ↗

Sea Vegetables and Fruits as Novel Dietary Protective Factors for Sarcopenia and Muscle Function in Taiwan: A Cross-Sectional StudySemantic proximity Read ↗

Primary tumor location is a risk factor for postoperative development of sarcopenia related to poor outcomes in patients with colorectal cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.